The piricardim all of the majors use hearts from Australian cows. So what is the diff if it is exported as raw product then turned into implantable tissue, or manufactured onshore, then exported as the end product? Only diff is labour cost (which is small as a % as evidenced by the 68% and set to increase to >75% gross margins)
- Forums
- ASX - By Stock
- AVR
- AHZ Accounting
AHZ Accounting, page-19
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.05 |
Change
0.000(0.00%) |
Mkt cap ! $327.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 73 | $17.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.80 | 9 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 73 | 17.400 |
1 | 191 | 17.150 |
1 | 178 | 17.050 |
2 | 55 | 17.000 |
1 | 196 | 16.950 |
Price($) | Vol. | No. |
---|---|---|
16.800 | 9 | 1 |
17.000 | 2812 | 1 |
17.150 | 90 | 1 |
17.500 | 500 | 1 |
17.800 | 200 | 1 |
Last trade - 11.19am 22/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable